Symphera, a Munich-based medical device startup, has raised €2.4 million in seed funding to advance its innovative surgical tool system.
The round was led by High-Tech Gründerfonds (HTGF) and included participation from Bayern Kapital, CARMA FUND, UnternehmerTUM, Stern Stewart Ventures, IRCAD, and business angels. The funding will be used to develop Symphera’s product and initiate pre-clinical tests as part of the certification process.
Advertisement
Automating Laparoscopic Procedures
Founded in 2023 and incubated at TU Munich and UnternehmerTUM, Symphera focuses on simplifying laparoscopic surgeries by automating tool-switching. The company’s system allows surgeons to switch between instruments at the push of a button, eliminating the need for manual changes and enabling greater focus during procedures. This innovation aims to reduce surgery time and improve patient outcomes by enhancing surgical precision and efficiency.
Investor Confidence in Symphera’s Vision
Dr. Jan Engels, Investment Manager at HTGF, emphasized that the company’s technology has the potential to transform the entire spectrum of laparoscopic procedures, including robot-assisted surgeries. Prof. Jacques Marescaux, Founder of IRCAD, praised the startup’s approach as revolutionary, expressing excitement about bringing this technology to operating rooms worldwide.
